Oita University Institute of Advanced Medicine Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
10
- Latest Deal Type
-
Out of Business
Oita University Institute of Advanced Medicine General Information
Description
Developer of a drug discovery platform designed to treat unmet medical needs worldwide. The company develops technology to assist and improve the drug discovery process and phases for the development of medicines in various therapeutic areas, enabling healthcare professionals to discover new drugs to cure diseases.
Contact Information
Website
www.oitaiam.comCorporate Office
- 4563-1 Niida
- Kochi, Kochi 781-0112
- Japan
Corporate Office
- 4563-1 Niida
- Kochi, Kochi 781-0112
- Japan
Oita University Institute of Advanced Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 01-May-2026 | Completed | Out of Business | |||
| 5. Later Stage VC | Completed | Generating Revenue | ||||
| 4. Later Stage VC | 29-Mar-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 05-Feb-2021 | Completed | Startup | |||
| 2. Early Stage VC | 03-Jun-2020 | $2.41M | $6.7M | Completed | Startup | |
| 1. Seed Round | 30-Nov-2018 | $4.29M | $4.29M | Completed | Startup |
Oita University Institute of Advanced Medicine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class B Preferred | ||||||||
| Class A Preferred |
Oita University Institute of Advanced Medicine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oita University Institute of Advanced Medicine Patents
Oita University Institute of Advanced Medicine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022124341-A1 | Novel peptidomimetic compound and design | Inactive | 09-Dec-2020 | ||
| WO-2022092294-A1 | Novel treatment and prevention of sarcopenia-related diseases | Inactive | 30-Oct-2020 | ||
| WO-2021161511-A1 | Compound and drug containing same | Inactive | 14-Feb-2020 | ||
| WO-2020246503-A1 | Cyclic amide compounds for rabies treatment and method thereof | Inactive | 03-Jun-2019 | ||
| JP-6890865-B1 | Cyclic amide compounds for the treatment of rabies and methods thereof | Active | 03-Jun-2019 | A61K31/439 |
Oita University Institute of Advanced Medicine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oita University Institute of Advanced Medicine FAQs
-
When was Oita University Institute of Advanced Medicine founded?
Oita University Institute of Advanced Medicine was founded in 2017.
-
Where is Oita University Institute of Advanced Medicine headquartered?
Oita University Institute of Advanced Medicine is headquartered in Kochi, Japan.
-
What is the size of Oita University Institute of Advanced Medicine?
Oita University Institute of Advanced Medicine has 10 total employees.
-
What industry is Oita University Institute of Advanced Medicine in?
Oita University Institute of Advanced Medicine’s primary industry is Drug Discovery.
-
Is Oita University Institute of Advanced Medicine a private or public company?
Oita University Institute of Advanced Medicine is a Private company.
-
What is Oita University Institute of Advanced Medicine’s current revenue?
The current revenue for Oita University Institute of Advanced Medicine is .
-
How much funding has Oita University Institute of Advanced Medicine raised over time?
Oita University Institute of Advanced Medicine has raised $8.51M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
